Medicare Advantage rates nudged up
CMS finalized a Medicare Advantage payment rule that lifts plan payments for 2027, giving insurers a short-term revenue boost. Markets reacted — managed-care shares rallied as investors reassessed near-term margin visibility — but analysts warn this doesn’t remove longer-term uncertainty around risk adjustment and reimbursement pressure. (Modern Healthcare) ((meyka.com))
Washington just gave Medicare Advantage insurers a bigger raise than Wall Street expected, and the surprise was large enough to send UnitedHealth, Humana, and CVS shares sharply higher on April 6 after the rate notice landed. The Centers for Medicare and Medicaid Services set a 2.48% average payment increase for 2027, far above the 0.09% increase it floated in January. (cms.gov) (reuters.com) Medicare Advantage is the version of Medicare run by private insurers instead of the government’s traditional fee-for-service program, and it is no longer a side business. In 2025, 34.1 million people, or 54% of eligible Medicare beneficiaries, were enrolled in these plans. (kff.org) The money move was bigger than the headline number suggests. A Medicare agency official told reporters insurers would also get about a 2.5% lift from changes tied to health-status risk assessment, bringing the total payment effect to roughly 5%. (reuters.com) That reversal mattered because insurers had spent months preparing for a much tighter 2027. The January advance notice pointed to just $700 million in extra payments, while the final April 6 notice projected more than $13 billion above 2026 levels. (cms.gov) (risehealth.org) Investors reacted like a pressure valve had opened. Reuters reported shares of UnitedHealth, CVS, and Humana rose between 8% and 14% in extended trading after the announcement, because higher government payments can cushion plans that have been squeezed by rising medical use. (reuters.com) The squeeze has been real. Insurers have been dealing with higher utilization, which is industry shorthand for members actually using more doctor visits, outpatient care, and hospital services than pricing assumed. (fiercehealthcare.com) (cnbc.com) But this was not a full retreat by regulators. In the same April 6 announcement, the Centers for Medicare and Medicaid Services said the policy package was meant to improve payment accuracy and strengthen long-term sustainability, which is Washington’s way of saying the government still thinks some payments are too generous or too easily inflated. (cms.gov) That fight centers on risk adjustment, the formula Medicare uses to pay more for sicker patients than healthier ones. If a plan documents more diagnoses, its payment rises, so every change to that formula can shift billions of dollars between taxpayers and insurers. (cms.gov) (medpac.gov) The government’s own Medicare Payment Advisory Commission has warned for years that coding intensity in Medicare Advantage makes beneficiaries look sicker on paper than similar people in traditional Medicare. In a 2024 chapter on coding and selection, the commission said those differences push payments above what Medicare would have spent for the same people in fee-for-service coverage. (medpac.gov) So the market heard two messages at once. April’s rate notice gave insurers a near-term revenue lift for 2027, but the same federal agencies are still rewriting the rules around star ratings, enrollment, and payment accuracy, with the separate 2027 final rule taking effect on June 1, 2026 and applying to coverage starting January 1, 2027. (cms.gov) (federalregister.gov) The simplest way to read the rally is this: insurers just got a bigger paycheck for next year, not a guarantee that the job gets easier after that. The 2027 numbers improved margin visibility for a sector that lives on thin forecasting edges, while the longer argument over diagnosis coding, reimbursement pressure, and how much Medicare should pay private plans is still very much alive. (modernhealthcare.com) (cms.gov)
